STAAR SURGICAL COMPANY

NASDAQ: STAA (STAAR Surgical Company)

最近更新时间: 2天之前, 6:29AM

19.04

-0.07 (-0.37%)

前收盘价格 19.11
收盘价格 19.09
成交量 893,356
平均成交量 (3个月) 1,340,614
市值 939,927,744
预期市盈率 (P/E Forward) 50.25
价格/销量 (P/S) 4.10
股市价格/股市净资产 (P/B) 2.67
52周波幅
13.50 (-29%) — 30.81 (61%)
利润日期 5 Nov 2025
营业毛利率 -25.46%
营业利益率 (TTM) -81.43%
稀释每股收益 (EPS TTM) -1.44
季度收入增长率 (YOY) -44.90%
季度盈利增长率 (YOY) 107.20%
总债务/股东权益 (D/E MRQ) 10.48%
流动比率 (MRQ) 4.78
营业现金流 (OCF TTM) -11.69 M
杠杆自由现金流 (LFCF TTM) 10.73 M
资产报酬率 (ROA TTM) -5.90%
股东权益报酬率 (ROE TTM) -19.14%

市场趋势

短期 中期
行业 Medical Instruments & Supplies (US) 看涨 混合的
Medical Instruments & Supplies (全球的) 看涨 看跌
股票 STAAR Surgical Company 看跌 看涨

AIStockmoo 评分

-1.8
分析师共识 1.0
内部交易活动 NA
价格波动 -2.0
技术平均移动指标 -3.5
技术振荡指标 -2.5
平均 -1.75

相关股票

股票 市值 DY P/E(TTM) P/B
STAA 940 M - - 2.67
MMSI 5 B - 44.30 3.20
ATRC 2 B - - 4.08
LMAT 2 B 0.94% 36.64 5.13
AZTA 2 B - 63.00 1.07
PLSE 970 M - - 11.03

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.

部门 Healthcare
行业 Medical Instruments & Supplies
投资方式 Small Growth
内部持股比例 0.64%
机构持股比例 109.43%

所有权

姓名 日期 持有股份
Broadwood Capital Inc 30 Sep 2025 13,519,491
Yunqi Capital Ltd 30 Sep 2025 2,500,061
Sand Grove Capital Management Llp 30 Sep 2025 829,123
American Capital Management Inc 30 Sep 2025 743,424
Defender Capital, Llc. 31 Dec 2025 668,222
Water Island Capital Llc 30 Sep 2025 658,317
52周波幅
13.50 (-29%) — 30.81 (61%)
目标价格波幅
21.50 (12%) — 30.75 (61%)
30.75 (Wells Fargo, 61.50%) 保留
22.00 (15.55%)
21.50 (Jefferies, 12.92%) 购买
平均值 24.75 (29.99%)
总计 1 购买, 2 保留
平均价格@调整类型 21.33
公司 日期 目标价格 调整类型 价格@调整类型
Jefferies 28 Jan 2026 21.50 (12.92%) 购买 19.04
Canaccord Genuity 16 Jan 2026 22.00 (15.55%) 保留 20.97
10 Dec 2025 30.75 (61.50%) 保留 23.99
Wells Fargo 10 Dec 2025 30.75 (61.50%) 保留 23.99

该时间范围内无数据。

日期 类型 细节
15 Jan 2026 公告 STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement
06 Jan 2026 公告 Alcon Terminates Agreement to Acquire STAAR Surgical
06 Jan 2026 公告 Broadwood Partners Comments on STAAR Surgical Shareholders’ Rejection of the Company’s Proposed Sale to Alcon
06 Jan 2026 公告 STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders
19 Dec 2025 公告 Broadwood Partners Denounces STAAR Surgical’s Fourth Delay of the Shareholder Vote on the Company’s Proposed Sale to Alcon
19 Dec 2025 公告 Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders
17 Dec 2025 公告 Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.
17 Dec 2025 公告 Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails
17 Dec 2025 公告 STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value
16 Dec 2025 公告 Yunqi Capital Comments on Proxy Advisors’ Updated Recommendations, Urges Shareholders to Continue to Back the Company’s Standalone Trajectory
16 Dec 2025 公告 Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction
16 Dec 2025 公告 Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon
15 Dec 2025 公告 Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote “FOR” Alcon Merger
12 Dec 2025 公告 Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation “AGAINST” STAAR Surgical Sale to Alcon
11 Dec 2025 公告 Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon
11 Dec 2025 公告 STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process
10 Dec 2025 公告 Yunqi Capital Comments on STAAR Surgical’s Go-Shop Process and Alcon’s Revised Offer
09 Dec 2025 公告 Broadwood Partners Responds to Alcon’s Increase to Proposed Acquisition Price of STAAR Surgical
09 Dec 2025 公告 Alcon Announces Amended Merger Agreement with STAAR Surgical
08 Dec 2025 公告 Broadwood Partners Reiterates Opposition to STAAR Surgical’s Sale to Alcon Following Conclusion of Performative Go-Shop Process
08 Dec 2025 公告 Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon
08 Dec 2025 公告 STAAR Surgical Announces Expiration of Go-Shop Period
02 Dec 2025 公告 Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors
10 Nov 2025 公告 Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical to Oversee Go-Shop Process
07 Nov 2025 公告 STAAR Surgical Announces Amendments to Alcon Merger Agreement
06 Nov 2025 公告 Yunqi Capital Applauds STAAR Surgical’s Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated
05 Nov 2025 公告 STAAR Surgical Reports Third Quarter 2025 Results
04 Nov 2025 公告 Broadwood Partners Condemns Alcon’s Fallacious Attacks on STAAR Surgical and Its Prospects
04 Nov 2025 公告 Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders
31 Oct 2025 公告 Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon
显示更多

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2026 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票